Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 10.66
-0.35 (-3.18%)
Nov 13, 2026, 3:04 PM CST
| Market Cap | 4.45B -32.9% |
| Revenue (ttm) | 488.84M +13.5% |
| Net Income | 53.64M +41.8% |
| EPS | 0.12 +31.2% |
| Shares Out | 417.60M |
| PE Ratio | 90.01 |
| Forward PE | n/a |
| Dividend | 0.06 (0.56%) |
| Ex-Dividend Date | Jun 12, 2026 |
| Volume | 6,739,298 |
| Open | 11.03 |
| Previous Close | 11.01 |
| Day's Range | 10.60 - 11.03 |
| 52-Week Range | 9.01 - 16.50 |
| Beta | 0.61 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 27, 2026 |